Absolute Bioavailability Of Bosutinib
NCT02192294
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Oral Bosutinib
DRUG:
Intravenous infusion of bosutinib
Sponsor
Pfizer